Results 161 to 170 of about 18,031 (200)

Low disease activity state in juvenile-onset systemic lupus erythematosus

Lupus, 2021
Objectives To determine the rate of achieving The Lupus Low Disease Activity State (LLDAS) in children with systemic lupus erythematosus (SLE) for tracing pertinent treatment modalities. Methods A total of 122 juvenile-onset SLE (jSLE) patients from six pediatric rheumatology centers in Turkey were enrolled in the study.
Kubra Ozturk, Senğul Caglayan, Ayse Tanatar, Esra Baglan, Gulcin Yener Otar, Gulsah Kavrul Kayaalp, Serife Gul Karadag, Ferhat Demir, Hafize Emine Sonmez, Semanur Ozdel, Mustafa Cakan, Nuray Aktay Ayaz, Betul Sozeri   +12 more
openaire   +3 more sources

Outcome in juvenile onset systemic lupus erythematosus

Current Opinion in Rheumatology, 2005
Over the past 2 decades, there has been a marked improvement in survival among patients with juvenile-onset systemic lupus erythematosus. As a result of the increased life expectancy, children and adolescents with systemic lupus erythematosus are now faced with considerable morbidity resulting from sequelae of disease activity, side effects of ...
RAVELLI, ANGELO, RUPERTO N, MARTINI, ALBERTO   +2 more
openaire   +3 more sources

Treatment Options for Juvenile-Onset Systemic Lupus Erythematosus

Pediatric Drugs, 2002
Systemic lupus erythematosus (SLE) is an inflammatory chronic disease characterized by the presence of activated helper T-cells that induce a B-cell response, resulting in the secretion of pathogenic autoantibodies and the formation of immune complexes.
Luis, Carreño, Francisco Javier, López-Longo, Carlos Manuel, González, Indalecio, Monteagudo   +3 more
openaire   +2 more sources

Anti‐C1q Antibodies in Juvenile‐Onset Systemic Lupus Erythematosus

Annals of the New York Academy of Sciences, 2009
The objective of this study was to evaluate the presence of anti‐C1q antibodies Hospital Israelita Albert Einstein Research Institute, São Paulo, Brazil in 67 juvenile systemic lupus erythematosus (JSLE) patients and 26 healthy controls and to assess the association of these antibodies with disease activity, nephritis, and presence of anti‐double ...
A A, Jesus, C A, Silva, M, Carneiro-Sampaio, M, Sheinberg, C L, Mangueira, S K, Marie, B L, Liphaus   +6 more
openaire   +2 more sources

Pulmonary hypertension in juvenile-onset systemic lupus erythematosus: a case series

Clinical and Experimental Rheumatology, 2022
Systemic lupus erythematosus (SLE) is a rare multisystem autoimmune disorder with a variable clinical phenotype. Pulmonary hypertension (PHTN) is a recognised (and not uncommonly asymptomatic) complication of the condition with an associated poor prognosis in adults.
Platt, Caroline, Longthorpe, Catherine, Sit, Jacqueline, Marks, Stephen D, Harmer, Matthew, Ciurtin, Coziana, Ramanan, Athimalaipet V, Beresford, Michael W   +7 more
openaire   +3 more sources

THU0330 Damage in juvenile-onset systemic lupus erythematosus

Annals of the Rheumatic Diseases, 2012
Background Children and adolescents with juvenile-onset systemic lupus erythematosus (jSLE) face considerable morbidity due to sequelae of disease activity, comorbidities and adverse effects of treatment. In order to improve the management of these patients, it is essential to better understand the risk factors associated with the development of ...
P. Costa Reis, J. Isgro, S. Nativ, C. Yildirim-Toruner, A. Starr, L. Imundo, A. Eichenfield   +6 more
openaire   +1 more source

Juvenile-onset systemic lupus erythematosus

2013
Paediatric or juvenile-onset systemic lupus erythematosus (JSLE) is a rare autoimmune condition, differing from the adult form in terms of severity, organ manifestations, and a less striking female predominance. The diagnosis relies on the adult-derived American College of Rheumatology SLE classification criteria. Genetic, autoantibody, and host immune
Louise Watson, Michael W. Beresford
openaire   +1 more source